Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|November 17, 2024
Limited Sampling Strategy for Predicting the Area under Plasma Concentration-Time Curve of Nadolol in Healthy SubjectsShingen Misaka, Yuko Maejima, Kenju Shimomura
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 4, 2008
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applicationsSatomi Onoue, Shingen Misaka, Shizuo Yamada
Current Opinion in Pharmacology|September 14, 2013
Clinical relevance of drug efflux pumps in the gutShingen Misaka, Fabian Müller, Martin F Fromm
Expert Opinion on Drug Delivery|June 30, 2009
New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapySatomi Onoue, Shingen Misaka, Yohei Kawabata, et al.
Journal of Clinical Pharmacology|January 2, 2021
Urinary Excretion of Nadolol as a Possible In Vivo Probe for Drug Interactions Involving P-GlycoproteinSho Shimazaki, Junko Kuroda, Kenju Shimomura, et al.
Drug Metabolism and Pharmacokinetics|February 20, 2013
Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in ratsNozomu Miyazaki, Shingen Misaka, Hiroshi Ogata, et al.
Frontiers in Endocrinology|June 26, 2024
Sex differences in the effects of aromatherapy on anxiety and salivary oxytocin levelsDaisuke Nakajima, Megumi Yamachi, Shingen Misaka, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2009
Novel dry powder formulation of ovalbumin for development of COPD-like animal model: Physicochemical characterization and biomarker profiling in ratsShingen Misaka, Hideyuki Sato, Yukinori Yamauchi, et al.
Peptides|October 28, 2010
Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosisShingen Misaka, Hideyuki Sato, Yosuke Aoki, et al.
International Journal of Pharmaceutics|March 23, 2011
Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model ratsSatomi Onoue, Yosuke Aoki, Takuya Matsui, et al.
Pageof 5